2nd Cell Therapy Analytical Development Summit Europe
Following the success of last year’s inaugural meeting, the 2nd Cell Therapy Analytical Development Summit Europe heads to Amsterdam this year as the only cell therapy-focused, industry-facing, European-specific summit in the space.
With FDA regulatory holds on release assays and potency forming a prevailing bottleneck in the cell therapy space, there has never been a more important time for the European cell therapy community to unite to implement gold standard analytical development, effectively communicate with the EMA and secure market approval.
Join 100+ analytical development, CMC and process development industry experts this September as they look to advance multi-region access, achieve consistent and scalable assay development and drive analytical standards to bring safe, high-quality cell therapies to patients across the European territories.
Hear from expert speakers across 3 jam-packed days of data-driven presentations and gain control of your manufacturing processes, assay development and analytical strategy with key thought leaders from the likes of Takeda, Novo Nordisk, Cellectis and Novartis.
